Zurich Cantonal Bank’s Filana Therapeutics FLNA Stock Holding History

Zurich Cantonal Bank’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,069	Closed	-$21.4K	–	2678
2024 Q4	$21.4K	Buy	9,069 +1,602	+21%	+$28.1K	﹤0.01%	2591
2024 Q3	$220K	Hold	7,467	–	–	﹤0.01%	2057
2024 Q2	$92.2K	Hold	7,467	–	–	﹤0.01%	2410
2024 Q1	$152K	Buy	7,467 +1,826	+32%	+$42.1K	﹤0.01%	2202
2023 Q4	$127K	Hold	5,641	–	–	﹤0.01%	2331
2023 Q3	$93.9K	Hold	5,641	–	–	﹤0.01%	2381
2023 Q2	$138K	Hold	5,641	–	–	﹤0.01%	2158
2023 Q1	$136K	Buy	5,641 +1,821	+48%	+$50.5K	﹤0.01%	2104
2022 Q4	$113K	Sell	3,820 -1,225	-24%	-$44K	﹤0.01%	2190
2022 Q3	$211K	Hold	5,045	–	–	﹤0.01%	1724
2022 Q2	$142K	Hold	5,045	–	–	﹤0.01%	1999
2022 Q1	$187K	Hold	5,045	–	–	﹤0.01%	1932
2021 Q4	$220K	Buy	5,045 +1,011	+25%	+$53K	﹤0.01%	2003
2021 Q3	$250K	Hold	4,034	–	–	﹤0.01%	1773
2021 Q2	$345K	Buy	+4,034	New	+$216K	﹤0.01%	1459

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Zurich Cantonal Bank's FLNA Position: Q1 2025 in Review

Zurich Cantonal Bank sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 9,069 shares — an estimated $21.4K sold.

Zurich Cantonal Bank first reported a position in FLNA in Q2 2021 and held it in 15 quarters. The position peaked at $345K in Q2 2021. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.

Zurich Cantonal Bank reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
Zurich Cantonal Bank sold 9,069 Filana Therapeutics shares in Q1 2025, an estimated $21.4K.
Zurich Cantonal Bank first reported a position in Filana Therapeutics in Q2 2021 and held it in 15 quarters.
Zurich Cantonal Bank's Filana Therapeutics position peaked at $345K in Q2 2021.
117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.

Based on Zurich Cantonal Bank's 13F filing for Q1 2025, filed 7 May 2025.